Amniotics AB (OSTO:AMNI) Price-to-Tangible-Book : 1.40 (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Price-to-Tangible-Book?

As of today (2024-06-14), Amniotics AB's share price is kr0.0042. Amniotics AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was kr0.00. Hence, Amniotics AB's Price to Tangible Book Ratio of today is 1.40.

The historical rank and industry rank for Amniotics AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 5 years, Amniotics AB's highest Price to Tangible Book Ratio was 3.86. The lowest was 1.40. And the median was 3.43.

OSTO:AMNI's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.8
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Amniotics AB's share price is kr0.0042. Amniotics AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was kr0.01. Hence, Amniotics AB's P/B Ratio of today is 0.70.

Amniotics AB Price-to-Tangible-Book Historical Data

The historical data trend for Amniotics AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Price-to-Tangible-Book Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

3.86

3.00

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial										9.17	-	10.22	-	3.00

Competitive Comparison of Amniotics AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Amniotics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amniotics AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amniotics AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Amniotics AB's Price-to-Tangible-Book falls into.

Amniotics AB Price-to-Tangible-Book Calculation

Amniotics AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.0042	/	0.003
	=	1.40

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Amniotics AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.